DRUG PRICING IN ADRIATIC COUNTRIES – IS REFERENCE PRICING THE BEST OPTION?

Author(s)

Dragana Atanasijevic, MD, MPH, MSc, Institute of Public Health of Serbia, Belgrade, Serbia; Tarik Čatić, PhD, Health Economics and Pharmacoeconomics, Sarajevo, Bosnia; Pero Draganić, PhD, MD, HALMED, Zagreb, Croatia; Rok Hren, PhD, MSc, Institute of Mathematics, Physics and Mechanics, Ljubljana, Slovenia

DESCRIPTION: Drug pricing rules and trends will be presented from the perspective of countries in the Adriatic region. Speakers will discuss each country’s experience and the impact of prices on access to medicines, its quality and pharmaceutical expenditure. Since most of the countries in the region share similar health care organization and financing system, it will be an opportunity to discuss trends and propose which model is the most suitable for these countries in order to effectively distribute pharmaceutical budgets and ensure access to medicines.

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Code

F5

Topic

Health Policy & Regulatory, Organizational Practices

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×